181
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Risk assessment in human immunodeficiency virus-associated acute myeloid leukemia

, , , , , , & show all
Pages 660-664 | Received 29 Jun 2011, Accepted 10 Sep 2011, Published online: 27 Apr 2012

References

  • Frisch M, Biggar RJ, Engles EJ, . Association of Cancer with HIV associated Immunosuppression in Adults. JAMA 2001;285:1736–1745.
  • Patel P, Hanson DL, Sulivan PS, . Incidence and Types of Cancer among HIV-Infected Persons Compared with the General Population in the United States, 1992–2003. Ann Intern Med 2008;148:728–736.
  • Sutton L, Guenel P, Tanguy ML, . Acute myeloid leukaemia in human immunodeficiency virus infected adults: epidemiology, treatment feasibility and outcome. Br J Hematol 2001;112:900–908.
  • Aboulafia DM, Meneses M, Ginsberg S, . Acute myeloid leukemia in patients infected with HIV-1. AIDS 2002;16:865–876.
  • Grimwade D, Walker H, Oliver F, . The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial. Blood 1998;92:2322–2333.
  • Slovak LM, Kopecky KJ, Cassileth PA, . Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study. Blood 2000;96:4075–4083.
  • Byrd JC, Mrozek K, Dodge RK, . Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia group B (CALGB). Blood 2002;100:4325–4336.
  • Arber DA, Stein AS, Carter NH, . Prognostic Impact of Acute Myeloid Leukemia Classification. Am J Clin Pathol 2003:119;672–680.
  • Hentrich M, Rockstroh J, Sandner R, . Acute myelogenous leukaemia and myelomonocytic blast crisis following polycytemia vera in HIV positive patients: Report of cases and review of the literature. Ann Oncol 2000;11:195–200.
  • King JAC, Nye DM, O'Connor MB, . Acute myelogenous leukemia (FAB AML-M1) in the setting of HIV infection and G-CSF therapy: a case report and review of the literature. Ann Hematol 1998;77:69–73.
  • Schneider E, Lambermont M, Van Vooren JP, . Autologous stem cell infusion for acute myeloblastic leukemia in an HIV-1 carrier. Bone Marrow Transplant 1997;20:611–612.
  • Manfredi R, Sabbatani S, Chiodo F. Advanced acute myelogenous leukaemia (AML) during HAART-treated HIV disease, manifesting initially as a thyroid mass. Scand J Infect Dis 2005;37:781–783.
  • Napoli VM, Stein SF, Spira TJ, . Myelodysplasia progressing to acute myeloblastic leukemia in an HTLV-III virus positive homosexual man with AIDS-related complex. Am J Clin Pathol 1986;86:788–791.
  • Gold JE, Babu A, Penchaszadeh V, . Hybrid acute leukemia in an HIV-antibody-positive patient. Am J Hematol 1998;30:240–247.
  • Wijermans PW, ten Kate RW. Successful chemotherapy for acute myeloid leukemia in HIV-infected patients. Eur J Haematol 1990; 44:136–138.
  • Puppo F, Schudletti M, Murgia L, . Acute myelomoncytic leukaemia in and HIV-infected patient. AIDS 1991;6:136–137.
  • Mansberg R, Rowlings PA, Yip MY, . First and second complete remissions in a HIV positive patient following remission induction therapy for acute non-lyphoblastic leukaemia. Aust NZ J Med 1991;21:55–57.
  • Farber CM, Ferehans W, Capel P, . Chemotherapy of acute myeloblastic leukemia in an HIV carrier. Eur J Haematol 1993;51:180.
  • Hennge UR, Schultwolter T, Uppenkamp T. Occurrence and therapy of secondary acute myeloid leukaemia in two HIV-infected patients. AIDS 1998;12:221–222.
  • Mangialardi WJ, Raffanti SP. Acute non-lymphoblastic leukemia with an unusual chromosomal abnormality in a patient with advance AIDS. AIDS 1998;12:1936–1937.
  • Drug-Associated HIV Transmission Continues in the United States. http://www.cdc.gov/hiv/resources/factsheets/PDF/idu.pdf.
  • Mehta SH, Kirk GD, Astemborski J, . Temporal trends in highly active antiretroviral therapy initiation among injection drug users in Baltimore, Maryland, 1996–2008. Clin Infect Dis 2010;50:1664–1671.
  • Hutter G, Nowak D, Mossner M, . Long-term control of HIV by CCR5 Delt32/Delta32 stem-cell transplantation. N Engl J Med (NEJM) 2009;360:692–698.
  • Allers K, Hutter G, Hofmann J, . Evidence for the cure of HIV infection by CCR5∆32/∆32 stem cell transplantation. Blood 2011;117:2791–2799.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.